Company Ticker News November 4, 2021Provention Bio, Inc. (PRVB) Reports Q3 Loss, Misses Revenue Estimates 0 0 Share
Company Ticker News November 4, 2021Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q3 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News September 16, 2021Provention Bio to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit 0 0 Share
Press Release September 13, 2021Provention Bio Provides Update on the Potential Timing of Teplizumab At-Risk Type 1 Diabetes (T1D) Biologics License Application (BLA) Resubmission 0 0 Share
Company Ticker News August 8, 2021Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q2 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News August 5, 2021Provention Bio Reports Second Quarter 2021 Financial Results and Provides Business Update 0 0 Share
Company Ticker News August 5, 2021Provention Bio, Inc. (PRVB) Reports Q2 Loss, Lags Revenue Estimates 0 0 Share
Press Release July 20, 2021PRVB Final Deadline Today: Rosen, Trusted Investor Counsel, Encourages Provention Bio, Inc. Investors to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVB 0 0 Share
Press Release July 19, 2021DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 0 0 Share
